{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:51:27Z","timestamp":1791247887137,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":92,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-60817-y","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T16:23:34Z","timestamp":1783355014000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Investigating the risk of non-alcoholic fatty liver disease in young patients with psoriasis versus non-psoriatic inflammatory skin diseases"],"prefix":"10.1038","volume":"16","author":[{"given":"Wei-Wei","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Ying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ju","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"key":"60817_CR1","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1001\/jama.2020.4006","volume":"323","author":"AW Armstrong","year":"2020","unstructured":"Armstrong, A. W & Read, C. Pathophysiology clinical presentation, and treatment of psoriasis: A review. JAMA 323, 1945\u20131960 (2020).","journal-title":"JAMA"},{"key":"60817_CR2","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.jaad.2018.11.058","volume":"80","author":"CA Elmets","year":"2019","unstructured":"Elmets, C. A. et al. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities. J. Am. Acad. Dermatol. 80, 1073\u20131113 (2019).","journal-title":"J. Am. Acad. Dermatol."},{"key":"60817_CR3","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.jaad.2018.11.057","volume":"80","author":"A Menter","year":"2019","unstructured":"Menter, A. et al. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics. J. Am. Acad. Dermatol. 80, 1029\u20131072 (2019).","journal-title":"J. Am. Acad. Dermatol."},{"key":"60817_CR4","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","volume":"397","author":"CEM Griffiths","year":"2021","unstructured":"Griffiths, C. E. M., Armstrong, A. W., Gudjonsson, J. E. & Barker, J. N. W. N. Psoriasis. Lancet 397, 1301\u20131315 (2021).","journal-title":"Lancet"},{"key":"60817_CR5","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.jaad.2024.03.058","volume":"92","author":"LM Perez-Chada","year":"2025","unstructured":"Perez-Chada, L. M. et al. Psoriatic arthritis: A comprehensive review for the dermatologist part I: Epidemiology, comorbidities, pathogenesis, and diagnosis. J. Am. Acad. Dermatol. 92, 969\u2013982 (2025).","journal-title":"J. Am. Acad. Dermatol."},{"key":"60817_CR6","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1056\/NEJMra1505557","volume":"376","author":"CT Ritchlin","year":"2017","unstructured":"Ritchlin, C. T., Colbert, R. A. & Gladman, D. D. Psoriatic arthritis. N Engl. J. Med. 376, 957\u2013970 (2017).","journal-title":"N Engl. J. Med."},{"key":"60817_CR7","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/j.jacc.2021.02.009","volume":"77","author":"MS Garshick","year":"2021","unstructured":"Garshick, M. S., Ward, N. L., Krueger, J. G. & Berger, J. S. Cardiovascular risk in patients with psoriasis: JACC review topic of the week. J. Am. Coll. Cardiol. 77, 1670\u20131680 (2021).","journal-title":"J. Am. Coll. Cardiol."},{"key":"60817_CR8","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1111\/jdv.18044","volume":"36","author":"JJ Wu","year":"2022","unstructured":"Wu, J. J., Kavanaugh, A., Lebwohl, M. G., Gniadecki, R. & Merola, J. F. Psoriasis and metabolic syndrome: implications for the management and treatment of psoriasis. J. Eur. Acad. Dermatol. Venereol. 36, 797\u2013806 (2022).","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"60817_CR9","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.jaad.2017.04.1133","volume":"77","author":"MJM Rodr\u00edguez-Z\u00fa\u00f1iga","year":"2017","unstructured":"Rodr\u00edguez-Z\u00fa\u00f1iga, M. J. M. & Garc\u00eda-Perdomo, H. A. Systematic review and meta-analysis of the association between psoriasis and metabolic syndrome. J. Am. Acad. Dermatol. 77, 657\u2013666e8 (2017).","journal-title":"J. Am. Acad. Dermatol."},{"key":"60817_CR10","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","volume":"77","author":"ME Rinella","year":"2023","unstructured":"Rinella, M. E. et al. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatol 77, 1797\u20131835 (2023).","journal-title":"Hepatol"},{"key":"60817_CR11","doi-asserted-by":"publisher","first-page":"4652","DOI":"10.3748\/wjg.v16.i37.4652","volume":"16","author":"YT Zhan","year":"2010","unstructured":"Zhan, Y. T. & An, W. Roles of liver innate immune cells in nonalcoholic fatty liver disease. World J. Gastroenterol. 16, 4652\u20134660 (2010).","journal-title":"World J. Gastroenterol."},{"key":"60817_CR12","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","volume":"397","author":"EE Powell","year":"2021","unstructured":"Powell, E. E., Wong, V. W. & Rinella, M. Non-alcoholic fatty liver disease. Lancet 397, 2212\u20132224 (2021).","journal-title":"Lancet"},{"key":"60817_CR13","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1136\/gutjnl-2020-320622","volume":"69","author":"G Targher","year":"2020","unstructured":"Targher, G., Byrne, C. D. & Tilg, H. NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications. Gut 69, 1691\u20131705 (2020).","journal-title":"Gut"},{"key":"60817_CR14","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1136\/gutjnl-2020-323082","volume":"71","author":"A Mantovani","year":"2022","unstructured":"Mantovani, A. et al. Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis. Gut 71, 156\u2013162 (2022).","journal-title":"Gut"},{"key":"60817_CR15","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1053\/j.gastro.2021.07.049","volume":"161","author":"F Kanwal","year":"2021","unstructured":"Kanwal, F. et al. Clinical care pathway for the risk stratification and management of patients with nonalcoholic fatty liver disease. Gastroenterol 161, 1657\u20131669 (2021).","journal-title":"Gastroenterol"},{"key":"60817_CR16","first-page":"517","volume":"19","author":"J Heitmann","year":"2021","unstructured":"Heitmann, J., Frings, V. G., Geier, A., Goebeler, M. & Kerstan, A. Non-alcoholic fatty liver disease and psoriasis - is there a shared proinflammatory network? J. Dtsch. Dermatol. Ges. 19, 517\u2013528 (2021).","journal-title":"J. Dtsch. Dermatol. Ges"},{"key":"60817_CR17","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.jaad.2013.10.044","volume":"70","author":"EA van der Voort","year":"2014","unstructured":"van der Voort, E. A. et al. Psoriasis is independently associated with nonalcoholic fatty liver disease in patients 55 years old or older: Results from a population-based study. J. Am. Acad. Dermatol. 70, 517\u2013524 (2014).","journal-title":"J. Am. Acad. Dermatol."},{"key":"60817_CR18","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1001\/jamadermatol.2022.1609","volume":"158","author":"Z Ruan","year":"2022","unstructured":"Ruan, Z. et al. Association between psoriasis and nonalcoholic fatty liver disease among outpatient US Adults. JAMA Dermatol. 158, 745\u2013753 (2022).","journal-title":"JAMA Dermatol."},{"key":"60817_CR19","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.jaad.2021.03.023","volume":"86","author":"JJ Yang","year":"2022","unstructured":"Yang, J. J., Nguyen, K. A., Fleischman, M. W., Aly, O. & Cheng, K. Psoriasis in liver disease: Associations beyond nonalcoholic fatty liver disease. J. Am. Acad. Dermatol. 86, 883\u2013885 (2022).","journal-title":"J. Am. Acad. Dermatol."},{"key":"60817_CR20","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.3390\/jcm14041374","volume":"14","author":"S Untaaveesup","year":"2025","unstructured":"Untaaveesup, S. et al. The risk of metabolic dysfunction-associated steatotic liver disease in moderate-to-severe psoriasis: A systematic review and meta-analysis. J. Clin. Med. 14, 1374 (2025).","journal-title":"J. Clin. Med."},{"key":"60817_CR21","doi-asserted-by":"publisher","first-page":"e0305217","DOI":"10.1371\/journal.pone.0305217","volume":"19","author":"S Tan","year":"2024","unstructured":"Tan, S. et al. Exploring the pathogenesis and immunological profiles of psoriasis complicated with MASLD. PloS One 19, e0305217 (2024).","journal-title":"PloS One"},{"key":"60817_CR22","doi-asserted-by":"publisher","first-page":"e13457","DOI":"10.1111\/srt.13457","volume":"29","author":"N Xian","year":"2023","unstructured":"Xian, N. et al. Bioinformatics analysis to reveal the potential comorbidity mechanism in psoriasis and nonalcoholic steatohepatitis. Skin. Res. Technol. 29, e13457 (2023).","journal-title":"Skin. Res. Technol."},{"key":"60817_CR23","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/bjd.16239","volume":"179","author":"RB Prussick","year":"2018","unstructured":"Prussick, R. B. & Miele, L. Nonalcoholic fatty liver disease in patients with psoriasis: a consequence of systemic inflammatory burden? Br. J. Dermatol. 179, 16\u201329 (2018).","journal-title":"Br. J. Dermatol."},{"key":"60817_CR24","doi-asserted-by":"publisher","first-page":"8593","DOI":"10.1038\/s41598-021-88043-8","volume":"11","author":"I Belinch\u00f3n-Romero","year":"2021","unstructured":"Belinch\u00f3n-Romero, I. et al. Non-alcoholic fatty liver disease is associated with bacterial translocation and a higher inflammation response in psoriatic patients. Sci. Rep. 11, 8593 (2021).","journal-title":"Sci. Rep."},{"key":"60817_CR25","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3390\/ijms17020217","volume":"17","author":"A Mantovani","year":"2016","unstructured":"Mantovani, A., Gisondi, P., Lonardo, A. & Targher, G. Relationship between non-alcoholic fatty liver disease and psoriasis: A novel hepato-dermal axis? Int. J. Mol. Sci. 17, 217 (2016).","journal-title":"Int. J. Mol. Sci."},{"key":"60817_CR26","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/j.1468-3083.2010.03841.x","volume":"25","author":"KS Wenk","year":"2011","unstructured":"Wenk, K. S., Arrington, K. C. & Ehrlich, A. Psoriasis and non-alcoholic fatty liver disease. J. Eur. Acad. Dermatol. Venereol. 25, 383\u2013391 (2011).","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"60817_CR27","doi-asserted-by":"publisher","first-page":"315","DOI":"10.4254\/wjh.v7.i3.315","volume":"7","author":"G Ganzetti","year":"2015","unstructured":"Ganzetti, G., Campanati, A. & Offidani, A. Non-alcoholic fatty liver disease and psoriasis: So far, so near. World J. Hepatol. 7, 315\u2013326 (2015).","journal-title":"World J. Hepatol."},{"key":"60817_CR28","first-page":"151","volume":"11","author":"DMW Balak","year":"2021","unstructured":"Balak, D. M. W., Piaserico, S. & Kasujee, I. Non-alcoholic fatty liver disease (NAFLD) in patients with psoriasis: A review of the hepatic effects of systemic therapies. Psoriasis (Auckl. 11, 151\u2013168 (2021).","journal-title":"Psoriasis (Auckl"},{"key":"60817_CR29","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.jhep.2009.04.020","volume":"51","author":"P Gisondi","year":"2009","unstructured":"Gisondi, P., Targher, G., Zoppini, G. & Girolomoni, G. Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis. J. Hepatol. 51, 758\u2013764 (2009).","journal-title":"J. Hepatol."},{"key":"60817_CR30","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s00125-019-05040-3","volume":"63","author":"B Tramunt","year":"2020","unstructured":"Tramunt, B. et al. Sex differences in metabolic regulation and diabetes susceptibility. Diabetologia 63, 453\u2013461 (2020).","journal-title":"Diabetologia"},{"key":"60817_CR31","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1016\/j.jacc.2022.02.010","volume":"79","author":"JG Regensteiner","year":"2022","unstructured":"Regensteiner, J. G. & Reusch, J. E. B. Sex differences in cardiovascular consequences of hypertension, obesity, and diabetes: JACC focus seminar 4\/7. J. Am. Coll. Cardiol. 79, 1492\u20131505 (2022).","journal-title":"J. Am. Coll. Cardiol."},{"key":"60817_CR32","doi-asserted-by":"publisher","first-page":"3498","DOI":"10.1210\/jc.2004-2240","volume":"90","author":"E Bugianesi","year":"2005","unstructured":"Bugianesi, E. et al. Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity. J. Clin. Endocrinol. Metab. 90, 3498\u20133504 (2005).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"60817_CR33","doi-asserted-by":"crossref","unstructured":"Bilson, J., Sethi, J. K. & Byrne, C. D. Non-alcoholic fatty liver disease: a multi-system disease influenced by ageing and sex, and affected by adipose tissue and intestinal function. Proc. Nutr. Soc. 81, 146\u2013161 (2022).","DOI":"10.1017\/S0029665121003815"},{"key":"60817_CR34","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1067\/mjd.2002.120470","volume":"46","author":"C Ferr\u00e1ndiz","year":"2002","unstructured":"Ferr\u00e1ndiz, C., Pujol, R. M., Garc\u00eda-Patos, V., Bordas, X. & Smand\u00eda, J. A. Psoriasis of early and late onset: a clinical and epidemiologic study from Spain. J. Am. Acad. Dermatol. 46, 867\u2013873 (2002).","journal-title":"J. Am. Acad. Dermatol."},{"key":"60817_CR35","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1111\/bjd.14886","volume":"175","author":"E Theodorakopoulou","year":"2016","unstructured":"Theodorakopoulou, E. et al. Early- and late-onset psoriasis: a cross-sectional clinical and immunocytochemical investigation. Br. J. Dermatol. 175, 1038\u20131044 (2016).","journal-title":"Br. J. Dermatol."},{"key":"60817_CR36","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1111\/bjd.16083","volume":"178","author":"L Chen","year":"2018","unstructured":"Chen, L. & Tsai, T. F. HLA-Cw6 and psoriasis. Br. J. Dermatol. 178, 854\u2013862 (2018).","journal-title":"Br. J. Dermatol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60817-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60817-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60817-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:57:43Z","timestamp":1791244663000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60817-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["60817"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-60817-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]},"assertion":[{"value":"12 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All methods were carried out in accordance with relevant guidelines and regulations, consistent with the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","label":"Ethical considerations","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study received ethical approval from the Institutional Review Board of Taichung Veterans General Hospital, Taiwan (No. CE23353C-2).","order":3,"name":"Ethics","label":"IRB approval status","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"31042"}}